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Hereditary epidermolysis bullosa (EB) is a group of rare
congenital diseases characterised by extreme epithelial
fragility, which determines the formation of bullae
and/or erosions either spontaneously or after local
mechanical traumas.1 Both the skin and the mucosae are
often involved. The severity of the disease is highly vari-
able: while milder forms do not alter significantly the
quality of life of the patients, more severe forms can be
lethal at birth or even before. According to the depth of
the lesions, EB is divided into three classes: simple, junc-
tional, and dystrophic.2 Various inheritance patterns are
possible, with the autosomal-recessive one being the most
frequent. Junctional EB (JEB) in particular is generally
caused by mutations in genes coding for proteins crucial
for dermal-epidermal junction (DEJ) formation. Dystro-
phic EB (DEB), on the contrary, is mainly linked to
mutations in the gene COL7A1, coding for collagen VII.
In EB patients, especially in DEB and JEB variants, skin
fragility leads to many possible complications and com-
orbidities. Apart from death during childhood due to
either sepsis or respiratory failure, JEB and DEB are often
burdened by ocular diseases, joint deformities, and a very
high incidence of cutaneous squamous cell carcinoma
(SCC).3,4 SCCs in EB patients generally arise in friction
areas, more often in the extremities, where chronic blis-
ters and scars are generally located. SCCs represent a big
therapeutic challenge in the EB population: wound clo-
sure after surgical excision is in fact often difficult.5 If, on
the one hand, primary suture in distal areas—often
characterised by erosions and scars—is sometimes impos-
sible, on the other hand, healthy donor sites for skin
grafting are rarely available. Therefore, secondary inten-
tion wound healing is a very frequently used strategy for
EB patients after surgical resections for oncological pur-
poses.4 In this setting, the use of dermal matrices could
find an important application. In fact, dermal scaffolds
are proven to enhance and accelerate granulation tissue
formation and to promote re-epithelization.6,7
The aim of our study was to compare the efficacy of a
commonly used dermal substitute (Matriderm®) and clas-
sical secondary-intention wound healing in determining
wound bed vascularization and wound closure after sur-
gery for SCC removal in EB patients.
MATERIALS AND METHODS
Two male patients affected by EB with invasive SCC of
the extremities were included in the present study. The
first patient (p1) was 32 years old and was affected by
DEB. He presented with an invasive SCC of the ulnar
margin of the left hand (see Figure 1A). The second
patient (p2) on the contrary was a 49-year-old man,
affected by JEB who referred to our centre for the pres-
ence of an invasive SCC of the right ankle (see
Figure 1B). Both patients underwent surgical excision of
the skin tumours. Then, while one patient
(p1) underwent dermal substitute positioning, the other
(p2) experienced second-intention wound closure (see
Figure 1C,D). In both cases, transepidermal water loss
and the infection risk were minimised through external
dressings. Patients had two scheduled follow-up visits at
day 15 (±5) and day 30 (±5) post-intervention (v1 and v2,
respectively). During the follow-up, patients underwent
not only clinical assessment but also microscopical evalu-
ation of the wound bed after skin sample collection. Both
classical histology with conventional haematoxylin and
eosin and immunostaining for CD31 were performed at
every timepoint.
RESULTS
Both patients had good clinical outcomes with complete
re-epithelization at v2. However, re-epithelization was
faster in the presence of dermal substitute, with better
outcomes at v1, thus lowering the need of advanced
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dressings and shortening the time at high risk of infec-
tion (see Figure 1E-H). Moreover, minor scarring was
developed after dermal substitute positioning, with a
score of 5 and 9, respectively, in patients 1 and
2 according to the Vancouver Scar Scale. A thicker epi-
dermis was shown to be present in histological sections
at v2 in the patient who was treated by Matriderm® posi-
tioning (Figure 2A,B). Revascularization of the wound
bed occurred efficiently in both cases. In particular, in
p1, vessels had a physiological distribution: in fact, CD31
+ capillaries at v2 were mainly localised in the superficial
and in the deep dermis, corresponding to the superficial
and deep vascular dermal plexuses, with only sporadic
anastomoses in the mid-dermis, as it happens under nor-
mal conditions. On the contrary, a hypervascularized der-
mis was evident in p2 at the same timepoint, as it often
occurs in scar tissues, with redundant vessels, not
restricted to vascular plexuses but diffused throughout
the dermis, following the tensile strength of the scar.
CONCLUSION
In conclusion, patients affected by EB—especially in the
junctional and dystrophic variants—have a 70-fold
increase of SCC in areas of ulceration and scarring that
often require demolitive surgery.8 In this setting, dermal
matrices seem to improve significantly surgical outcomes
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FIGURE 1 Legend on next column.
FIGURE 1 Clinical pictures of the two EB patients before and
after surgery. Patient 1 (p1): left column. Patient 2 (p2): right
column. Panels A and B: p1 and p2 with squamous cells'
carcinomas of the extremities before surgical intervention. Panels C
and D: p1 and p2 3 days after surgery. Panels E and F: p1 and p2
15 days after surgery (visit 1, v1). Panels G and H: p1 and p2
30 days after surgery (v2)
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FIGURE 2 CD31 staining for endotheliocytes while in p2 vessels were oriented linearly (panel B), following the tensile strength of the
scar, a more physiological distribution of vascular structures throughout the dermis was observed in p1 (panel A)
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